CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology

Takeda reiterates the need of equitable access to healthcare for universal impact

The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery

Eye-Q launches Johnson and Johnson’s ELITA SILK procedure in India

This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses

IIM Kashipur inks MoU with Max Healthcare to launch PG Diploma Programme in Hospital Management

AI to transform all processes in drug development by 2026, predicts CPHI Report

In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs

JB Pharma publishes sustainability report for FY 2022-23

JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions

SÜDPACK Medica presents PharmaGuard at CPHI in Barcelona

SÜDPACK customers also benefit when it comes to processing PharmaGuard

Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit

The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards